Showing results (1181-1190 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 1, 1984
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin GH C Korting, H Behrendt, K H Roth, et al.Chemotherapy|January 1, 1984
Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn ratsK S Kim, M Manocchio, A S BayerChemotherapy|January 1, 1978
Antibiotic X-63 in experimental candidiasis of miceH P Gupta, I S Mathur, S K GuptaChemotherapy|January 1, 1982
Clinical and pharmacokinetic evaluation of moxalactam in infants and childrenM Varghese, A J Khan, G Quaye, et al.Chemotherapy|January 1, 1982
Study of the diffusion of cefotiam in the bronchial secretionsE Bergogne-Berezin, G Berthelot, H KafeChemotherapy|January 1, 1982
Cefotaxime (HR-756) in urinary tract infectionsF Paradisi, P Cristiano, V Mirone, et al.Chemotherapy|January 1, 1981
Perinatal listeriosis. Tolerance of a clinical isolate of Listeria monocytogenes for ampicillin and resistance against cefotaximeW H TraubChemotherapy|January 1, 1984
Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosaP H Chandrasekar, R F Schell, J L LeFrock, et al.Chemotherapy|January 1, 1984
The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosaK V Rolston, P H Chandrasekar, J L LeFrock, et al.Chemotherapy|January 1, 1981
Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiencyG M Trager, A P Panwalker, J B Malow, et al.Pageof 308